Oakworth Capital’s Medpace MEDP Stock Holding History

Oakworth Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-9	Closed	-$3.71K	–	729
2024 Q2	$3.71K	Hold	9	–	–	﹤0.01%	612
2024 Q1	$3.64K	Hold	9	–	–	﹤0.01%	575
2023 Q4	$2.76K	Buy	+9	New	+$2.43K	﹤0.01%	600

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Oakworth Capital's MEDP Position: Q3 2024 in Review

Oakworth Capital sold out of Medpace (MEDP) in Q3 2024, closing a stake of 9 shares — an estimated $3.71K sold.

Oakworth Capital first reported a position in MEDP in Q4 2023 and held it in 3 quarters. The position peaked at $3.71K in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

Oakworth Capital reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
Oakworth Capital sold 9 Medpace shares in Q3 2024, an estimated $3.71K.
Oakworth Capital first reported a position in Medpace in Q4 2023 and held it in 3 quarters.
Oakworth Capital's Medpace position peaked at $3.71K in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Oakworth Capital's 13F filing for Q3 2024, filed 21 Oct 2024.